New Weight-Loss drug HS235 passes early safety check in small study
NCT ID NCT06714825
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This early-stage study tested a new drug called HS235 in 39 overweight or obese but otherwise healthy adults aged 40 and older. The main goal was to check the drug's safety and how the body processes it. Researchers measured side effects and drug levels in the blood to understand its effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Syneos Clinical Research Unit
Québec, Quebec, Canada
Conditions
Explore the condition pages connected to this study.